# Ernexa Therapeutics Inc.: Form 8-K, filed Feb 25, 2021

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2021-02-25
- Accepted by EDGAR: Feb 25, 2021, 07:02 ET
- Period: 2021-02-25
- Accession: 0001493152-21-004770
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000149315221004770/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000149315221004770/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000149315221004770/form8-k.htm

Filed Feb 25, 2021.
Source: SEC EDGAR, the filing index for accession 0001493152-21-004770. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.
